Investor Relations

Investors

View the Latest Stock Trading Information

Review BioStem’s latest trading data, historical quotes, volume, and key statistics.

Learn More

News

Sign Up with Email Alerts Today.

Get news, filings, and events directly in your inbox with our automated Email Alerts

Sign Up

Symbol
OTC : BSEM
Price
$
Volume
Change
Delayed up to 15 minutes
Investor Relations

BioStem Technologies

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain® processing method. BioRetain® has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (AATB). These systems and procedures are established per current Good Tissue Practices (cGTP) and current Good Manufacturing Processes (cGMP). Its portfolio of quality brands includes AmnioWrap2®, VENDAJE®, VENDAJE AC® and VENDAJE OPTIC®. Each BioStem Technologies placental allograft is processed at the Company’s FDA registered and AATB accredited site in Pompano Beach, Florida.
Press Releases

Latest News

Quarterly
Results

Stock
Information

Presentations
& Brochures

Upcoming
Events